Potential mechanisms underlying this variability may include tRF‐22 targeting genes or signaling pathways beyond hnRNPAB in other cancer types, as well as its regulation being influenced by co‐expressed regulatory factors or transcriptional variations. Here, HNRNPAB is linked to cancer.